WASHINGTON, Oct. 21, 2013 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical
company focused on the development and commercialization of
products for the treatment of central nervous system disorders,
today announced it will release results for the third quarter of
2013 on Thursday, November 7, 2013,
before the market opens.
The Company will host a conference call at 10:00 AM ET on Thursday,
November 7, 2013, during which Vanda management will discuss
the financial results. To participate in the conference call,
please dial 1-888-895-5271 (domestic) or 1-847-619-6547
(international) and use passcode 35919679.
The conference call will be broadcast simultaneously and
archived on the Company's website, www.vandapharma.com.
Investors should go to the website at least 15 minutes early
to register, download, and install any necessary audio
software.
A replay of the call will be available on Thursday, November 7, 2013, beginning at
12:00 PM ET and will be accessible
until Thursday, November 14, 2013, at
5:00 PM ET. The replay call-in
number is 1-888-843-7419 for domestic callers and 1-630-652-3042
for international callers. The passcode number is
35919679.
ABOUT VANDA PHARMACEUTICALS
INC.:
Vanda Pharmaceuticals Inc. is
a biopharmaceutical company focused on the development and
commercialization of products for the treatment of central nervous
system disorders. For more on Vanda Pharmaceuticals Inc.,
please visit www.vandapharma.com.
Investor Contact:
Chad Rubin
Vice President
The Trout Group
(646) 378-2947
crubin@troutgroup.com
SOURCE Vanda Pharmaceuticals Inc.